The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Moderna Inc’s current trading price is -84.96% away from its 52-week high, while its distance from the 52-week low is 7.91%. The stock’s price range for this period has been between $23.76 and $170.47 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 13.24 million for the day, a number notably higher than the average daily volume of 11.94 million over the last three months.
Moderna Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $170.47 on 05/24/24, while the lowest price for the same duration was marked at $23.76 on 04/07/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Moderna Inc (MRNA) has experienced a quarterly decline of -39.21% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.89B and boasts a workforce of 5800 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 37.03, with a change in price of -21.19. Similarly, Moderna Inc recorded 10,856,631 in trading volume during the last 100 days, posting a change of -45.25%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MRNA stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.07.
MRNA Stock Stochastic Average
Moderna Inc’s raw stochastic average for the past 50 days is presently 11.32%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 16.63%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 8.77% and 7.12%, respectively.
MRNA Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price decrease of -38.34%. However, over the past six months, we’ve seen a stronger performance of -58.02%. The price of MRNA leaped by -28.00% over the last 30 days. And in the last five days, it has fallen by -9.56%.
